Cerebral Microembolism in Cardiology
- Conditions
- Cerebral Embolism
- Interventions
- Device: Transcranial Doppler (TCD) ultrasound measurement
- Registration Number
- NCT03802760
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Brief Summary
During different interventional cardiology procedures we aim to identify cerebral microemboli load. Further we aim to differentiate the quality and the quantity of cerebral microemboli.We will measure cerebral microemboli in different interventional phases, e.g. during valve deployment, rapid pacing, post-implantation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
- Age > 18 years
- Interventional cardiology procedure (TAVI, MitraClip, TricuspidalClip)
- Allergy to ultrasound gel or materials contained in the TCD probe
- Missing temporal bone window
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description MitraClip patients Transcranial Doppler (TCD) ultrasound measurement Patients undergoing MitraClip implantation TricuspidalClip Transcranial Doppler (TCD) ultrasound measurement Patients undergoing TricuspidalClip implantation TAVI patients Transcranial Doppler (TCD) ultrasound measurement Patients undergoing transfemoral TAVI
- Primary Outcome Measures
Name Time Method Quality of cerebral microemboli (solid vs. gaseous) intraoperative phase, expected to be approx. 4 hours The quality of cerebral microemboli is measured by Doppler ultrasonography which automatically detects and analyses the Doppler signal coming from the middle cerebral artery. According to the strength of signal reflection, the signal will be qualified as solid or gaseous.
- Secondary Outcome Measures
Name Time Method Quantity of cerebral microemboli load intraoperative phase, expected to be approx. 4 hours The quantity of cerebral microemboli is measured by Doppler ultrasonography which automatically register the counts of solid and gaseous emboli.
Cerebral hemispheric differences (left vs. right) intraoperative phase, expected to be approx. 4 hours
Trial Locations
- Locations (1)
Department of Anesthesiology and Pain Medicine
🇨🇭Bern, Switzerland